Dr. Haley Brooke Dodd is a pharmacist who is specialized in Oncology in Griffin, Georgia. Patients can reach her at 747 S 8th St Ste C, Griffin or contact her on 770-228-1767. Active license number of Dr. Haley Brooke Dodd is RPH032255 for Oncology in Georgia. Dr. Haley Brooke Dodd is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Dr. Haley Brooke Dodd speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Dr. Haley Brooke Dodd
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Female
Location:
747 S 8th St Ste C, Griffin, Georgia, 30224-4884
Phone:
770-228-1767
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Haley Brooke Dodd are as mentioned below.
NPI Number:
1205664521
NPI Enumeration Date:
26 Jul, 2024
NPI Last Update On:
26 Jul, 2024
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Haley Brooke Dodd are as mentioned below.
Specialization
License Number
State
Status
Oncology
RPH032255
Georgia
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
189 Adams Rd, Meansville, Georgia
Zip:
30256-2319
Phone Number:
770-876-5434
Fax Number:
--
Patients can reach Dr. Haley Brooke Dodd at 747 S 8th St Ste C, Griffin, Georgia or can call on phone at 770-228-1767.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.